Salako Olanrewaju A, Akindele Abidemi J, Balogun Aishat O, Adeyemi Olufunmilayo O
Department of Pharmacology, Therapeutics & Toxicology (PTT), Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.
Drug Res (Stuttg). 2019 Feb;69(3):136-143. doi: 10.1055/a-0651-7978. Epub 2018 Aug 3.
Linn. (Musaceae) is used in traditional African medicine in the management of mental disorders. This study was conducted to evaluate the central nervous system activities of the aqueous leaf extract of (MS) MATERIALS AND METHODS: MS (50, 100 and 200 mg/kg, .) was administered to separate groups of mice 1 h before behavioural studies. The antidepressant effect was studied using the forced swimming test (FST) and tail suspension test (TST) while the elevated plus maze (EPM) and the hole-board tests were used to evaluate the anxiolytic effect. The probable mechanism of antidepressant-like effect was also investigated.
MS (50, 100 and 200 mg/kg) produced significant (0.0001) reduction in the duration of immobility with peak effect at 200 mg/kg (79.6%) in FST and 66.9 % in TST respectively when compared with control. The pre-treatment of mice with prazosin (α-adrenoceptor antagonist, 62.5 µg/kg, ) and sulpiride (dopamine D receptor antagonist, 50 mg/kg, ) significantly prevented the antidepressant effect produced by MS in FST. However, pre-treatment of mice with metergoline (5-HT receptor antagonist, 4 mg/kg, .) and yohimbine (α-adrenoceptor antagonist, 1 mg/kg, ) did not prevent the antidepressant effect of MS. In the EPM test, MS did not significantly increase open arm exploration. It also did not significantly increase the number of head dips in the hole-board test.
Results showed that MS had antidepressant activity possibly mediated through α-adrenergic and D dopaminergic receptors, without significant anxiolytic effect.
(芭蕉科)在非洲传统医学中用于治疗精神障碍。本研究旨在评估(MS)叶水提取物的中枢神经系统活性。材料与方法:在行为学研究前1小时,将MS(50、100和200mg/kg,.)分别给予不同组的小鼠。使用强迫游泳试验(FST)和悬尾试验(TST)研究抗抑郁作用,同时使用高架十字迷宫(EPM)和洞板试验评估抗焦虑作用。还研究了抗抑郁样作用的可能机制。
与对照组相比,MS(50、100和200mg/kg)显著(0.0001)缩短了不动时间,在FST中200mg/kg时达到峰值效应(79.6%),在TST中为66.9%。用哌唑嗪(α-肾上腺素能受体拮抗剂,62.5μg/kg,.)和舒必利(多巴胺D受体拮抗剂,50mg/kg,.)预处理小鼠可显著阻止MS在FST中产生的抗抑郁作用。然而,用美替拉酮(5-羟色胺受体拮抗剂,4mg/kg,.)和育亨宾(α-肾上腺素能受体拮抗剂,1mg/kg,.)预处理小鼠并未阻止MS的抗抑郁作用。在EPM试验中,MS未显著增加开放臂探索次数。在洞板试验中,它也未显著增加头部探洞次数。
结果表明,MS具有抗抑郁活性,可能通过α-肾上腺素能和D多巴胺能受体介导,无显著抗焦虑作用。